F

Florence Healthcare

Platform automates clinical trial site workflows

Vice President – Clinical Trial Platform

Full-TimeUpdated on 10/23/2026
No salary listed
Expert
Bachelor's, MBA
Atlanta, GA, USA
In Person
ProductTechnical Product Management

About the job

Requirements
  • At least 7 years of experience within clinical trial operations or clinical technologies, gained at or working with a sponsor, contract research organization, major site network, academic institution, or life sciences consulting practice.
  • Direct knowledge of study operational workflows, including site selection, study startup, essential document management, monitoring, and Sponsor-Site alignment.
  • Working understanding of 21 CFR Part 11, EU Annex 11, ICH GCP E6(R3), and regulatory compliance requirements within computerized systems validation.
  • At least 8 years managing B2B SaaS product portfolios, including a minimum of 3 years leading product management teams.
  • A demonstrated track record scaling platform ecosystems beyond single-point features, including shared data architecture, APIs, external integrations, and partner strategies.
  • Ability to partner with technical leadership on overall platform architecture, data structures, and AI/ML implementations.
  • Ability to align cross-functionally across Product, Engineering, Customer Success, and Sales, with executive-level communication for clients and stakeholders.
Responsibilities
  • Define how Sponsor and Site applications function as an integrated ecosystem, establishing shared data strategy, cross-product workflows, and integrations with CTMS, EDC, eTMF, and external systems.
  • Serve as the internal authority on operational workflows and translate clinical experience into platform direction for product managers and engineering units.
  • Partner with Engineering and AI teams to identify where automated agents can minimize operational work for sponsors and sites, delivering features in alignment with GxP and 21 CFR Part 11 requirements.
  • Drive platform expansion, cross-product attachment, and platform-driven ARR and retention metrics; partner across Sales, Marketing, Finance, and Customer Success on packaging, pricing, and go-to-market strategies.
  • Direct integration and partner ecosystem strategy, including APIs and agent frameworks such as MCP, and assist Corporate Development with build, buy, or partner decisions.
  • Monitor traditional eClinical providers, emerging AI-driven platforms, and evolving guidelines such as ICH E6(R3), translating market dynamics into long-term product decisions.
  • Establish an aligned platform vision and 12-month strategic roadmap endorsed by executive leadership, product, and engineering within the first 90 days.
  • Deploy initial cross-product workflows connecting Sponsor and Site solutions in active production with design partners within six months.
  • Within 12 months, demonstrate reductions in site effort and trial activation timelines while meeting platform retention and attach goals.
Desired Qualifications
  • Prior tenure at an eClinical platform organization, such as eReg/eISF, CTMS, eTMF, or site enablement solutions.
  • Proven experience delivering AI or machine learning functionality within regulated software platforms.
  • Background in a high-growth startup or venture-backed environment.
  • An MBA or advanced science degree.

About the company

FlorenceHC provides a Site Enablement Platform for clinical trials. The platform is subscription-based and helps sponsors, CROs, and trial sites manage electronic Investigator Site Files (eISFs), electronic Trial Master Files (eTMFs), and electronic binders (eBinders) by automating workflows such as creation, editing, signing, gathering, and reviewing documents. It also aims to reduce bottlenecks in site start-up and streamline the process from First Patient In (FPI) to Last Patient Out (LPO. The product works through a cloud-based platform that supports end-to-end trial documentation and site activation, alongside onboarding and adoption services to help clients start quickly. FlorenceHC differentiates itself with its ease of use, straightforward setup, and strong customer support, making it a trusted choice for sponsors and sites. The company’s goal is to accelerate clinical development and reduce trial costs, contributing to faster development of cures.

Company Size

201-500

Company Stage

Series C

Total Funding

$115.8M

Headquarters

Atlanta, Georgia

Founded

2014

Get referred to Florence Healthcare

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Florence claims 600-plus sponsors and CROs across 90 countries, scaling network effects.
  • The June 2026 MCP launch lets Claude and ChatGPT automate compliance checks and study monitoring.
  • Enrollment Automation, launched January 2025, expands Florence beyond documents into patient accrual workflows.

What critics are saying

  • Revelio data shows headcount fell from 412 in 2023 to 367 by March 2026.
  • Active job postings dropped 40% in 2026, signaling slower expansion and tighter sales execution.
  • If sponsors adopt generic AI agents, Florence’s interface layer becomes replaceable by 2027.

What makes Florence Healthcare unique

  • Florence’s June 2026 MCP layer exposes eleven workflows across 65,000 sites and 30,000 protocols.
  • AWS Marketplace distribution for SiteLink, launched October 28, 2025, shortens enterprise procurement.
  • Direct integrations with CTMS, EDC, eReg, and IRB reduce site workflow duplication.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Medical and dental insurance

Growth & Insights and Company News

6 month growth

0%

1 year growth

0%

2 year growth

0%
PR Newswire
Jun 16th, 2026
Florence Healthcare launches AI agent access across 65,000 research sites and 30,000 protocols

Florence Healthcare has announced Model Context Protocol access across its clinical trial software suite, enabling AI agents to interact with its eleven workflow tools spanning 65,000 research sites and 30,000 active protocols. The integration works with AI assistants including Anthropic's Claude and OpenAI's ChatGPT. The MCP layer allows AI agents to query and analyse clinical trial data in real-time, automating tasks such as identifying missing documents, detecting compliance gaps and monitoring study progress. In a demonstration, Florence showcased a "Trial Intelligence" workflow where users manage studies through natural language queries. The pre-revenue company aims to reduce administrative burden in clinical research by automating operational detective work. Florence Healthcare supports over 600 sponsors and contract research organisations across 90 countries, claiming its platform can accelerate study startup by up to 70 per cent.

Florence Healthcare
Jan 8th, 2025
Shankar Jagannathan Joins Florence Healthcare as Chief Operating Officer

Florence announces Shankar Jagannathan as their new Chief Operating Officer, bringing his extensive experience to enhance their leadership in Site Enablement Solutions for clinical trials.

Florence Healthcare
Jan 8th, 2025
Florence Launches Enrollment Automation Solutions

Florence Healthcare Launches New Enrollment Automation Solutions to Streamline Clinical Trial Enrollment for Sites and Sponsors Florence Healthcare, a leader in intelligent clinical trial workflow automation, has launched a new suite of participant enrollment automation solutions at its annual Research Revolution event. These solutions are designed to streamline the participant

BNN Breaking
Feb 20th, 2024
Slope and Florence Healthcare Forge Partnership to Revolutionize Clinical Trials Globally

The partnership between Slope and Florence Healthcare aims to revolutionize the clinical trial landscape by integrating their platforms and enhancing efficiencies.

Newswire
Nov 15th, 2023
Yunu Integration To Florence Improves Imaging Accuracy And Workflow Efficiency

Partnership extends capability for trial imaging integration to Florence Healthcare’s 18,000 activated clinical trial sites. . .